(Q40555429)

English

Rapid induction of autoantibodies against Nogo‐A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases

scientific article published on October 16, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rapid induction of autoantibodies against Nogo-A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rapid induction of autoantibodies against Nogo‐A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases (English)

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

1

object named as

Doron Merkler

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563689

22 March 2024

Daniel D Pinschewer

4

object named as

Daniel D. Pinschewer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563689

22 March 2024

author name string

Thomas Oertle

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Armin Buss

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Lisa Schnell

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Martin Kerschensteiner

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Florence M. Bareyre

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563689

22 March 2024

Bigna S. Buddeberg

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563689

22 March 2024

Martin E. Schwab

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563689

22 March 2024

language of work or name

0 references

publication date

16 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

full work available at URL

http://www.fasebj.org/cgi/content/abstract/17/15/2275

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563689

22 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.02-1203fje

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

https://onlinelibrary.wiley.com/doi/full-xml/10.1096/fj.02-1203fje

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

2275-2277

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

2

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord

3

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors

4

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A.

5

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors

6

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy

7

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Induction of antibodies against murine full-length prion protein in wild-type mice

9

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

10

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.

11

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord

12

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

13

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

14

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.

15

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

The T lymphocyte in experimental allergic encephalomyelitis

16

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.

17

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy.

18

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Breakdown of the blood-brain barrier after fluid percussive brain injury in the rat. Part 1: Distribution and time course of protein extravasation

19

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Approaching the asymptote? Evolution and revolution in immunology

20

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design

21

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

B-T lymphocyte interactions in the generation and survival of memory cells.

22

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

23

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

24

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Inhibitor of neurite outgrowth in humans

25

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions.

26

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury

27

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

30

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice

31

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat

34

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

'Semifree-floating' treatment: a simple and fast method to process consecutive sections for immunohistochemistry and neuronal tracing.

35

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

rMAL is a glycosphingolipid-associated protein of myelin and apical membranes of epithelial cells in kidney and stomach

38

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

39

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat.

40

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier.

41

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens

42

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

43

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

44

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Prognosis of multiple sclerosis: environmental factors

45

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Nerve inflammation halts trial for Alzheimer's drug.

46

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Alzheimer's vaccine: a cure as dangerous as the disease?

47

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology

48

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis

49

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis

50

1 reference

10.1096/FJ.02-1203FJE

https://api.crossref.org/works/10.1096/FJ.02-1203FJE

22 March 2024

Identifiers

10.1096/FJ.02-1203FJE

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40555429&oldid=2109411281"